BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Marketing

Ono Pharmaceutical Wins EU Approval for Vimseltinib as First TGCT Therapy

Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European Union Ono Pharmaceutical Co., a...

September 19, 2025 | News

EC Approves Alteogen’s EYLUXVI® as Eylea® Biosimilar for Major Ophthalmic Indications

EYLUXVI® is the second biosimilar approved for Alteogen following the launch of the Herceptin® biosimilar in China through it...

September 18, 2025 | News

Neusoft Medical Secures China’s First Approval For Photon-Counting CT With NeuViz P10

Neusoft Medical Systems announced that its NeuViz P10 photon-counting CT has received market approval from China's National Medical Product...

August 28, 2025 | News

QT Imaging secures $33M exclusive distribution deal with Gulf Medical for breast imaging scanners in Saudi Arabia

Shipments of five scanners per quarter starting on Q1’26 for total revenue of approximately $33 million over three years QT Imaging H...

August 26, 2025 | News

BioDlink Secures Indonesian Approval for Bevacizumab, Accelerating ASEAN and Global Expansion

BioDlink announced that its Bevacizumab Injection has obtained marketing authorization from Indonesia's National Agency of Drug and Food Con...

August 22, 2025 | News

GenScript Launches ‘Scripting Possibilities’—A Bold Global Brand Identity to Power the Future of Life Sciences

GenScript Biotech Corporation (HK.1548), a global leader in life sciences innovation, unveiled its new global brand platform: Scripting Possibilities...

August 11, 2025 | News

GC Biopharma Secures Vietnam Approval for Antibiotic-Free Varicella Vaccine BARYCELA

GC Biopharma (006280.KS), a South Korean pharmaceutical company, announced that its varicella vaccine BARYCELA has received marketing authorization from th...

July 18, 2025 | News

ImmunityBio Secures First International Approval for ANKTIVA® in the UK for Bladder Cancer Treatment

ANKTIVA, a first-in-class, lymphocyte-stimulating agent, works synergistically with BCG to activate and proliferate natural killer (NK) and T cells, he...

July 08, 2025 | News

Joincare Group Secures Greater China Rights to BRII-693 in Pact With Brii Biosciences

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater China Brii Biosciences retains ex-Greater China rights to a...

July 04, 2025 | News

Takara Bio Europe Partners with MACHEREY-NAGEL to Distribute Bioanalysis Portfolio Across Europe

Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and...

July 02, 2025 | News

Mabwell Grants Qilu Pharmaceutical Greater China Rights to Next-Generation Long-Acting G-CSF Albipagrastim Alfa

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its wholly-owned subsidiary T-mab has entered into an ag...

June 30, 2025 | News

BioDlink Secures NAFDAC Approval for Bevacizumab Injection, Marking Strategic Entry into the African Market

BioDlink's Bevacizumab Injection has been granted marketing authorization by Nigeria's National Agency for Food and Drug Administration an...

June 17, 2025 | News

JW Therapeutics Secures Macao Approval for CAR-T Therapy Carteyva®, Marking First Overseas Market Entry

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunother...

June 05, 2025 | News

FUJIFILM Unifies Life Sciences Brands to Deliver End-to-End Drug Development Solutions

FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences, providing a full spectrum of life sciences solutions built from a 55-year history as a c...

June 04, 2025 | News

Stay Connected